Harnessing Tissue Specific Activation of Inducible Cytokines for Treatment of Oncology and Autoimmunity

Time: 10:00 am
day: Conference Day Two


Outlining Werewolf Therapeutics PREDATOR™ technology

Exploring how technology takes advantage of protease selective linkers

Rendering biologically potent cytokines inactive in the periphery but allow activation in the disease target tissue of interest